• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: A Randomized Trial of Prenatal n−3 Fatty Acid Supplementation and Preterm Delivery

byConstance Wu
November 14, 2019
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

1. A multicenter randomized control trial concluded that n-3 polyunsaturated fatty acid supplementation in pregnancy did not change the risk of preterm delivery or the risk of post-term induction or cesarean section.

2. The safety profile of n-3 polyunsaturated fatty acid supplementation in pregnancy was similar to control.

Evidence Rating Level: 1 (Excellent)  

Study Rundown: Preterm delivery, delivery before 37 weeks of gestation, is associated with increased childhood morbidity and mortality. N-3 long-chain polyunsaturated fatty acids are known to play a role in modulating proinflammatory prostaglandins such as PGE2 and PGF2a that are associated with cervical ripening and uterine contractility. In this multicenter, double-blind randomized control trial, researchers assessed whether supplementation of n-3 long chain fatty acids between 14 and 34 weeks of gestation would lead to a lower rate of preterm delivery and lower neonatal complications after delivery. Participants in this study were randomized to take supplements of n-3 long chain polyunsaturated fatty acids or a control supplement largely consisting of isocaloric vegetable oil. Overall, researchers noted no difference in preterm delivery rates between groups. There also was no noted difference in the rate of post-term induction of labor or the rate of post-term cesarean section.

Click to read the study in NEJM

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc

RELATED REPORTS

#VisualAbstract: Extended Caffeine Does Not Reduce Hospitalization Time for Apnea in Moderately Preterm Infants

Atosiban does not improve neonatal outcomes in threatened preterm births between 30-34 weeks

Characterization of meconium-related obstruction and outcomes in term and preterm infants

Tags: n−3 fatty acidsneonatologyNICUpreterm birth
Previous Post

#VisualAbstract: Complete Revascularization with Multivessel PCI for Myocardial Infarction

Next Post

Elexacaftor-tezacaftor-ivacaftor is efficacious in treating cystic fibrosis patients with Phe508del-minimal function genotypes

RelatedReports

#VisualAbstract: Extended Caffeine Does Not Reduce Hospitalization Time for Apnea in Moderately Preterm Infants
StudyGraphics

#VisualAbstract: Extended Caffeine Does Not Reduce Hospitalization Time for Apnea in Moderately Preterm Infants

May 21, 2025
Increased complications associated with emergent repeat cesarean
Obstetrics

Atosiban does not improve neonatal outcomes in threatened preterm births between 30-34 weeks

May 1, 2025
Poverty, preterm birth demonstrate additive effect on cognition
Career Development

Characterization of meconium-related obstruction and outcomes in term and preterm infants

February 21, 2025
Racial, ethnic differences in outcomes of extremely preterm infants decreasing but persistent
Emergency

Comparison of different types of ultrasound probes for lung ultrasound in neonates

July 12, 2024
Next Post
Significant number of wrong-patient errors in radiology reports

Elexacaftor-tezacaftor-ivacaftor is efficacious in treating cystic fibrosis patients with Phe508del-minimal function genotypes

Quick Take: Factors associated with successful discontinuation of immune suppression after allogenic hematopoietic cell transplantation

Gilteritinib more effective than salvage chemotherapy for FLT3-mutated acute myeloid leukemia

#VisualAbstract: Previsit Screening for Parental Vaccine Hesitancy

#VisualAbstract: Previsit Screening for Parental Vaccine Hesitancy

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vaporized nicotine products may be effective for smoking cessation among people with social disadvantage
  • #VisualAbstract: Brain Activation Measured on Functional MRI Predicts Response to Certolizumab, a TNF Inhibitor, in Rheumatoid Arthritis
  • 2 Minute Medicine Rewind July 14, 2025
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.